Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis A: a preventable threat.

Alexander K C Leung1, James D Kellner, H Dele Davies

  • 1Department of Pediatrics, University of Calgary, Alberta Children's Hospital, Calgary, Alberta, Canada.

Advances in Therapy
|March 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence of Recurrent Invasive Pneumococcal Disease in Canada.

JAMA network open·2026
Same author

Expression and Correlation Analysis of Neuropeptide Family Members in the Peripheral Blood of Patients with COVID-19.

Current pediatric reviews·2026
Same author

A Narrative Review of Dietary Interventions and Supplementation for the Prevention and Treatment of Atopic Dermatitis.

Current pediatric reviews·2026
Same author

mRNA COVID-19 vaccine safety in adults from the Canadian national vaccine safety network.

Vaccine·2026
Same author

Safety of COVID-19 and influenza vaccines in children and adolescents with immunocompromised or autoimmune conditions: Findings from the Canadian National Vaccine Safety (CANVAS) network.

Human vaccines & immunotherapeutics·2026
Same author

Post-licensure safety of nirsevimab from the Canadian National Vaccine Safety (CANVAS) network.

Human vaccines & immunotherapeutics·2026

Hepatitis A poses a significant public health risk, especially for children. Universal childhood vaccination is the most effective strategy for preventing hepatitis A transmission and eradicating the disease.

Area of Science:

  • Hepatology
  • Virology
  • Public Health

Background:

  • Hepatitis A is a significant public health concern, particularly affecting pediatric populations.
  • While not causing chronic liver disease, hepatitis A infection leads to considerable morbidity.
  • Transmission occurs primarily through the fecal-oral route, posing risks via person-to-person contact.

Purpose of the Study:

  • To summarize the epidemiology, clinical presentation, diagnosis, and prevention of Hepatitis A.
  • To highlight the importance of vaccination in controlling Hepatitis A outbreaks.

Main Methods:

  • Review of existing literature on Hepatitis A.
  • Analysis of transmission routes and disease severity in pediatric populations.
  • Evaluation of diagnostic methods and preventive strategies.

Related Experiment Videos

Main Results:

  • Hepatitis A severity is inversely related to a child's age.
  • Diagnosis is typically confirmed by detecting immunoglobulin M (IgM) anti-hepatitis A antibodies.
  • Supportive care is the primary treatment, with hygiene and sanitation as general preventive measures.

Conclusions:

  • Universal childhood vaccination is the most effective method for eradicating Hepatitis A.
  • Vaccination and improved sanitation are crucial for preventing Hepatitis A transmission.